|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different trealment strategies in type 2 diabetes mellitus with stable ischemic heart disease : impact of treatment strategy on cardiac mortality and myocardial infarction 显示文摘 | Chaitman BR Hardison RM Adler D | 2009 | Circulation2009，120，： | 1 |
| 2 | Resting heart rate and metabolic syndrome in patients with diabetes and coronary artery disease in bypass angioplasty revascularization investigation 2 diabetes (BARI 2D) trial显示文摘 | Rana JS Hardison RM Pop-Busui R | 2010 | Prey Cardiol2010，13，3： | 1 |
| 3 | High prevalence and di- versity of kidney dysfunction in patients with type 2 diabetes mellitus and coronary artery disease: the BARI 2D baseline data显示文摘 | Wall BM Hardison RM Molitch ME | 2010 | Am J Med Sci2010，339，： | 1 |
| 4 | Comparison ofplasminogen activator inhibitor -1, tissue type plasminogenactivator antigen, fibrinogen, and D-dimer levels in variousage decades in patients with type 2 diabetes mellitus and stablecoronary artery disease (from the BARI 2D trial) 显示文摘 | Mcbane RN Hardison RM Sobel BE | 2010 | Am JCardiol’2010，105，1： | 1 |
| 5 | Association between increased platelet P-selectin expression and obesity in patients with type 2 diabetes:a BARI2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) substudy显示文摘 | Schneider DJ Hardison RM Lopes N | | 0，，05： | 1 |
| 6 | Profibrinolytie, Antithrombotic, and Antiinflammatory Effects of an Insulin- Sensitizing Strategy in Patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial显示文摘 | Sobel BE Hardison RM Genuth S | 2011 | Circulation2011，124，6： | 1 |
| 7 | High prevalence and diversity of kidney dysfunction in patients with type 2 diabetes mellitus and coronary artery disease:the BARI 2D baseline data显示文摘 | Wall BM Hardison RM Molitch ME | | 0，，： | 1 |
| 8 | Association between increased platelet P-selectin expression and obesity in patients with type 2 diabetes:a BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) substudy显示文摘 | Schneider DJ Hardison RM Lopes N | 2009 | Diabetes Care2009，32，5： | 1 |
| 9 | Comparison of plasminogen activator inhibitor-1,tissue type plasminogen activator antigen,fibrinogen,and D-dimer levels in various age decades in patients with type 2 diabetes mellitus and stable coronary artery disease显示文摘 | McBane RD 2nd Hardison RM Sobel BE BARI 2D Study Group | 2010 | Am J Cardiol2010，105，1： | 1 |
| 10 | Comparison of plasminogen activator inhibitor-l,tissue type plasminogen activator antigen,fibrinogen,and D-dimmer levels in various age decades in patients with type 2 diabetes mellitus and stable coronary artery disease (from the BARI 2D trial)显示文摘 | McBane RD 2nd Hardison RM Sobel BE | 2010 | Am J Cardio 12010，105，1： | 1 |
| 11 | Com- parison of plasminogen aetivator inhibitor-l, tissue type plasminogen activator antigen, fibrinogen, and D-dimer levels in various age decades in patients with type 2 dia- betes mellitus and stable coronary artery disease (from the BARI 2D trial)显示文摘 | McBane RD 2ndl Hardison RM Sobel BE | 2010 | Am J Cardiol2010，105，1： | 1 |
| 12 | Association between increased platelet P-selectin expression and obesity in patients with type 2 diabetes: a bypass angioplasty revascularization investigation 2 diabetes (BARI 2D) substudy显示文摘 | Schneider DJ Hardison RM Lopes N | 2009 | Diabetes Care2009，32，： | 1 |
| 13 | Comparison of plasminogen activator inhibitor-1,tissue type plasminogen activator antigen,fibrinogen,and D-dimer levels in various age decades in patients with type 2 diabetes mellitus and stable coronary artery disease (from the BARI 2D trial)显示文摘 | Mcbane RN Hardison RM Sobel BE | | 0，，01： | 1 |
| 14 | The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and myocardial infarction 显示文摘 | Chairman BR Hardison RM Adler D | 2009 | Circulation2009，120，25： | 1 |
| 15 | The Bypass Angioplasty Revas- cularization Investigation 2 Diabetes randomized trial of different treatment strat- egies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and myocardial infarction 显示文摘 | Chaitman BR Hardison RM Adler D | 2009 | Circulation2009，120，： | 1 |
| 16 | Comparison of plasminogen activator inhibitor-1, tissue type plasminogen activator antigen,fibrinogen, and D-dimer levels in various age decades in patients with type 2 diabetes mellitus and stable coronary artery disease (from the BARI 2D trial) 显示文摘 | McBane RD 2nd Hardison RM Sobel BE | 2010 | Am J Cardiol2010，105，1： | 1 |
| 17 | Comparison of plasmi-nogen activator inhibitor-1,tissue type plasminogen activatorantigen, fibrinogen, and D-dimer levels in various age decades inpatients with type 2 diabetes mellitus and stable coronary arterydisease(from the BARI 2D trial) 显示文摘 | McBane RD 2nd Hardison RM Sobel BE | 2010 | Am J Cardiol2010，105，1： | 1 |
| 18 | The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease : impact of treatment strategy on cardiac mortality and myocardial infarction 显示文摘 | Chaitman BR Hardison RM Adler D | 2009 | Circulation2009，120，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员